Lobe Sciences Ltd.
LOBE.CN News Today: Stay Updated with the Latest Lobe Sciences Ltd. News in Real Time
Find LOBE.CN news now at Meyka AI. Stay informed with the latest Lobe Sciences Ltd. stocks updates, including price news, market analysis, and expert insights.
^DJI Today April 02: Dow Rallies on Iran Ceasefire Hopes, Oil Cools
Dow Jones rises as Iran ceasefire hopes lift risk appetite and oil prices fall. What this means for Singapore investors, STI sectors, and key Dow levels to watch today.
RACE.NS up 20.00% pre-market on NSE 02 Apr 2026: volume spike signals momentum
RACE.NS stock jumps 20.00% pre-market on NSE; high volume and technicals show possible follow-through for short-term traders
Jefferies Maintains Buy on Protagonist Therapeutics (PTGX) PT $121 Mar 2026
PTGX analyst rating update: Jefferies, Johnson Rice maintain Buy; PT $121 and royalty model cited
UU.L Stock Today: Citywire Expert View Puts Utility in Focus – April 01
United Utilities in focus after Citywire Expert View. What UU.L stock investors in the UK should watch now: regulation, capex, income case, and near-term catalysts.
Germany’s Retirement Overhaul April 2: Riester Successor Fuels ETF Boom
Germany’s Riester successor could boost ETF saving plans with state subsidy savings from 2027. What it means for the German retirement plan market, ETF brokers in Germany, and long-term returns.
CHF153.40 pre-market spike: First Solar (FSLR.SW) SIX volume surge, catalyst ahead
FSLR.SW stock jumps to CHF153.40 pre-market on a volume spike; we parse catalysts, valuation and Meyka AI forecast
NYC Child Care April 01: Survey and Free On-site Pilot Signal Workforce Shift
NYC child care shifts on April 1 as the city launches a parent survey and a free on‑site pilot at 1 Centre Street. What it means for workers, budgets, and providers.
17,700 volume spike in 2107.T stock JPX: Pre-market 02 Apr 2026 watch targets
Pre-market volume spike in 2107.T stock at **17,700** shares on JPX; quick valuation and targets for investors
Barclays Maintains Overweight on Incyte (INCY) Mar 2026
INCY analyst rating: Barclays maintained Overweight on Incyte in Mar 2026, implications for investors and price context